This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To evaluate changes in endothelial cell count after pterygium surgery with mitomycin C (MMC) 0.02%

Provided treatments

  • Drug: Mitomycin C 0.02%
  • Procedure: Pterygium surgery

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02641132. The sponsor of the trial is Meir Medical Center and it is looking for 62 volunteers for the current phase.
Official trial title:
The Comparison of Endothelial Cell Count in Pterygium Surgery Relating to the Timing of MMC Application.